Brief History of Cardiac Arrhythmias since the End of the Nineteenth Century: Part II

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 1, 2004, Pages 101-111

  Surawicz, Borys ^a,b  

^a Care Group   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CALCIUM CHANNEL; COCAINE; DIGITALIS; DILTIAZEM; FLUNARIZINE; IODIDE; LIDOCAINE; POTASSIUM SALT; PROCAINAMIDE; QUINIDINE; RECEPTOR; STROPHANTHIDIN; VERAPAMIL;

ARTIFICIAL HEART PACEMAKER; BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM CURRENT; CALCIUM TRANSPORT; CARDIOVERSION; CATHETER ABLATION; CORONARY ARTERY THROMBOSIS; DEFIBRILLATION; DEFIBRILLATOR; DRUG ACTIVITY; DRUG CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; ELECTRODE; ELECTROSTIMULATION THERAPY; ENDOCARDIUM; EXTRASYSTOLE; GENE MAPPING; GENETIC DISORDER; HEART ARRHYTHMIA; HEART AUTOMATICITY; HEART BEAT; HEART CONDUCTION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART EXCITATION; HEART INFARCTION; HEART MUSCLE EXCITABILITY; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART PROARRHYTHMIA; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE; HEART VENTRICLE FIBRILLATION; HISTORY; HUMAN; INOTROPISM; LONG QT SYNDROME; MEMBRANE DEPOLARIZATION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PURKINJE FIBER; REENTRY ARRHYTHMIA; REFRACTORY PERIOD; REVIEW; SINUS RHYTHM; SODIUM CURRENT; SUDDEN DEATH; SYNCOPE; TIME;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ELECTRIC COUNTERSHOCK; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 0742324953     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.83320.x     Document Type: Review

References (144)

1. Mines GR: On circulating excitation in heart muscle and their possible relation to tachycardia and fibrillation. Trans Royal Soc Can 1914;8:43-52.
2. Schmitt FO, Erlanger J: Directional differences in the conduction of the impulse through heart muscle and their possible relation to extrasystolic and fibrillary contractions. Am J Physiol 1928;87:326-347.
3. Han J, Malozzi AM, Moe GK: Sinoatrial reciprocation in the isolated rabbit heart. Circ Res 1968;22:355-362.
4. Paulay KI, Varghese PJ, Damato AN: Sinus node reentry. An in vivo demonstration in the dog. Circ Res 1973;32:455-463.
5. Allessie MA, Bonke FI: Direct demonstration of sinus node reentry in the rabbit heart. Circ Res 1979;44:557-568.
6. Narula OS: Sinus node reentry. A mechanism for supraventricular tachycardia. Circulation 1974;50:1114-1128.
7. Wu D, Amat-y-Leon F, Denes P, Dhingra RC, Pietras RJ, Rosen KM: Demonstration of sustained sinus and atrial reentry as a mechanism of paroxysmal supraventricular tachycardia. Circulation 1975;51:234-243.
8. Bonke FI, Bouman LN, Schopman FYG: Effect of an early premature beat on activity of the sinoatrial node and atrial rhythm in the rabbit. Circ Res 1971;29:704-715.
9. Allessie MA, Bonke FI, Schopman F: Circus movement in rabbit atrial muscle as a mechanism of tachycardia. Circ Res 1973;33:54.
10. Akhtar M, Caracta SH, Lau SH, et al: Demonstration of intraatrial conduction delay, block gap and reentry. A report of two cases. Circulation 1978;58:947-955.
11. Wellens HJ: Unusual examples of supraventricular re-entrant tachycardia. Circulation 1975;51:997-1002.
12. Lewis T, Drury AN, Iliescu CC: A demonstration of circus movement in clinical flutter of the auricles. Heart 1921;8:341.
13. Waldo AL, MacLean WAH, Karp RB, et al: Entrainment and interruption of atrial flutter with atrial pacing. Studies in man following open heart surgery. Circulation 1977;56:737-745.
14. West TC, Landa JF: Minimal mass required for induction of a sustained arrhythmia in isolated atrial segments. Am J Physiol 1962;202:232-236.
15. Moe GK, Rheinholdt WC, Abildskov JA: A computer model of atrial fibrillation. Am Heart J 1964;67:200-220.
16. Allessie MA, Rensma PL, Brugada J, et al: Pathological physiology of atrial fibrillation. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology from Cell to Bedside. Philadelphia: WB Saunders, 1990:548-558.
17. Pick A, Langendorf R: A case of reciprocal beating with evidence of repetitive and blocked reentry of the cardiac impulse. Am Heart J 1950;40:13.
18. Surawicz B: Electrophysiologic Basis of ECG and Cardiac Arrhythmias. Malvern, PA: Williams & Wilkins, 1995:286.
19. Moe GK, Preston JB, Burlington H: Physiologic evidence for a dual A-V transmission system. Circ Res 1956;4:357-375.
20. Moe GK, Mendez C: The physiologic basis of reciprocal rhythms. Prog Cardiovasc Dis 1966;8:461-482.
21. Bigger JT, Goldreyer BN: The mechanism of supraventricular tachycardia. Circulation 1970;62:673-678.
22. Goldreyer BN, Damato AN: The essential role of atrioventricular conduction delay in the initiation of paroxysmal supraventricular tachycardia. Circulation 1971;63:679-687.
23. Damato AN, Lau SH, Bobb G: Studies on ventriculo-atrial conduction and the reentry phenomenon. Circulation 1970;41:423-435.
24. Wellens HJJ, Wesdorp JC, Duren DR, Lie KI: Second degree block during reciprocal atrioventricular nodal tachycardia. Circulation 1976;53:595-599.
25. Denes P, Wu D, Dhingra RC, Chuquimia R, Rosen KM: Demonstration of dual AV nodal pathways in patients with paroxysmal supraventricular tachycardia. Circulation 1973;68:549-555.
26. Wu D, Denes P, Dhingra RC, et al: Determinants of fast-and slow-pathway conduction in patients with dual atrioventricular nodal pathways. Circ Res 1975;36:782-790.
27. Rosen KM, Bauerfeind RA, Swiryn S, et al: Dual AV nodal pathways and AV nodal reentrant paroxysmal tachycardia. Am Heart J 1981;101:691-695.
28. Lown B, Ganong WF, Levine SA: The syndrome of short P-R interval, normal QRS complex and paroxysmal rapid heart action. Circulation 1952;5:693-706.
29. Wu D, Denes P, Amat-y-Leon F, et al: An unusual variety of atrioventricular nodal reentry due to retrograde dual atrioventricular nodal pathways. Circulation 1977;56:50-59.
30. Moe GK, Mendez C, Han J: Aberrant AV impulse propagation in the dog heart. A study of functional bundle branch block. Circ Res 1965;27:691-703.
31. Akhtar M, Damato AN, Batsford WP: Demonstration of reentry within the His Purkinje system in man. Circulation 1974;50:1150.
32. Wallace AG, Mignone RJ: Physiologic evidence concerning the reentry hypothesis for ectopic beats. Am Heart J 1966;72:60-70.
33. Sasyniuk BI, Mendez C: A mechanism for reentry in canine ventricular tissue. Circ Res 1971;28:3-15.
34. Allessie MA, Bonke FI, Schopman FJ: Circus movement in rabbit atrial muscle as a mechanism of tachycardia. The "leading circle" concept: A new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 1977;41:9-18.
35. Wit AL, Cranefield PF, Hoffman BF: Slow conduction and reentry in the ventricular conducting system: Single and sustained circus movement in networks of canine and bovine Purkinje fibers. Circ Res 1972;30:11-22.
36. El Sherif N, Hope RR, Scherlag BJ, et al: Reentrant ventricular arrhythmias in the late myocardial infarction period. Circulation 1977;55:686-702.
37. Schoels W, Gough WB, Restivo M, et al: Circus movement atrial flutter in the canine sterile pericarditis model: Activation patterns during initiation, termination, and sustained reentry in vivo. Circ Res 1990;67:35-50.
38. Spach MS: Anisotropic structural complexities in the genesis of reentrant arrhythmias. Circulation 1991;84:1447-1450.
39. Spach MS, Dolber PC, Heidlage JF: Interaction of inhomogeneities of repolarization with anisotropic propagation in dog atria. Circ Res 1989;65:1612-1631.
40. Fenoglio JJ, Pham TD, Harken AH, et al: Recurrent sustained ventricular tachycardia: Structure and ultra-structure of subendocardial regions in which tachycardia originates. Circulation 1983;68:518-533.
41. Dillon SM, Allessie MA, Ursell PC, Wit AL: Influence of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res 1988;63:182-206.
42. Peters NS, Severs NJ, Coromilas J, Wit AL: Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 1997;95:988-996.
43. Peters NS, Coromilas J, Hanna MS, Josephson M, Costeas C, Wit AL: Characteristics of the temporal and spatial excitable gap in anisotropic reentrant circuits causing sustained ventricular tachycardia. Circ Res 1998;82:279-293.
44. Pertsov AM, Davidenko JM, Salomon SZ, Baxter WT, Jalife J: Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res 1993;72:631-650.
45. Goldreyer BN, Gallagher JJ, Damato AN: The electrophysiologic demonstration of atrial ectopic tachycardia in man. Am Heart J 1973;85:205-215.
46. Gillette PC, Garson A Jr: Electrophysiologic and electropharmacologic characteristics of automatic ectopic atrial tachycardia. Circulation 1977;56:571-575.
47. Wellens HJJ, Lie KI, Durrer D: Further observations on ventricular tachycardia as studied by electrical stimulation of the heart. Circulation 1974;39:647-658.
48. Palileo EV, Ashley WW, Swiryn S, et al: Exercise provocable right ventricular outflow tract tachycardia. Am Heart J 1982;104:185-193.
49. Vassalle M: Analysis of cardiac pacemaker potential using a "voltage clamp" technique. Am J Physiol 1966;210:1335-1341.
50. f origins and developments. Prog Biophys Mol Biol 1985;46:163-183.
51. Jalife J, Hamilton AV, Moe GK: Effects of current flow on pacemaker activity of the isolated kitten sinoatrial node. Am J Physiol 1980;238:H307-H316.
52. Lu HH, Lange G, Brooks CM: Factors controlling pacemaker action in cells of the sinoatrial node. Circ Res 1965;17:460-471.
53. Sperelakis N: Electrical properties of embryonic heart cells. In De Mello WC, ed: Electrical Phenomena of the Heart. New York: Academic Press, 1972.
54. Cranefield PF: The Conduction of the Cardiac Impulse. The Slow Response and Cardiac Arrhythmias. Mount Kisco, NY: Futura Publishing Co., 1975.
55. Imanishi S, Surawicz B: Automatic activity in depolarized guinea pig ventricular myocardium. Characteristics and mechanisms. Circ Res 1976;39:751-759.
56. Cranefield PF: Action potentials, afterpotentials and arrhythmias. Circ Res 1977;41:415-423.
57. Reiter M: Die Entstehung von "Nachkontraktionen" im Herzmuskel unter Einwirkung von Calcium und on Digitalisglykosiden in Abhaengigkeit von der Reizfrequenz. Arch Exp Path U Pharmak 1962;242:497-507.
58. Ferrier GR: Relationship between acetylstrophanthidin-induced transient depolarizations in canine Purkinje tissues. Circ Res 1976;38:156-162.
59. Lown B, Kleiger R, Williams J: Cardioversion and digitalis drugs: Changed threshold to electric shock in digitalized animals. Circ Res 1965;17:519-531.
60. Ferrier G, Saunders JH, Mendez CA: cellular mechanism for the generation of ventricular arrhythmias by acetylstrophanthidin. Circ Res 1973;32:600-609.
61. Rosen MR, Gelband H, Merker C, Hoffman BF, et al: Mechanisms of digitalis toxicity: Effects of ouabain on phase four of canine Purkinje fiber transmembrane potentials. Circulation 1973;67:681-689.
62. Lederer WJ, Tsien RW: Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres. J Physiol (Lond) 1976;263:73-100.
63. Vos MA, Gorgels APM, Leuhissen JDH, Wellens HJJ, et al: Flumarizine allows differentiation between mechanisms of arrhythmias in the intact heart. Circulation 1990;81:343.
64. Sano T, Sawanobori T: Abnormal automaticity in canine Purkinje fibers focally subjected to low external calcium. Circ Res 1972;31:158-64.
65. Antzelevitch C, Dumaine R: Electrical heterogeneity in the heart: Physiological, pharmacological, and clinical implications. In: Handbook of Physiology. Section 2. The Cardiovascular System. Volume I. The Heart. New York: Oxford University Press, 2001:654-692.
66. Janse MJ, Van Capelle FJ, Morsin KH et al: Flow of "injury" current and pattern of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts. Circ Res 1980;47:151-165.
67. Davies MJ: Pathology of conducting tissue of the heart. London: Butterworth, 1971.
68. Truex RC, Bishof JK, Hoffman EL: Accessory atrioventricular muscle bundles of the developing human heart. Anat Rec 1958;45:131-142.
69. Mahaim I: Kent's fibers and the A-V para-specific conduction through the upper connections of the bundle of His-Tawara. Am Heart J 1947;33:651-653.
70. Brechenmacher C, Laham J, Iris L, Gerbaux A, Lenègre J: Étude histologique des voies anormales de conduction dans an syndrome Wolff-Parkinson-White et dans an syndrome de Lown-Ganong-Levine. Arch Mal Coeur 1974;67:507-519.
71. Durrer D, Roos JP: Epicardial excitation of the ventricles in a patient with Wolff-Parkinson-White syndrome (type B). Circulation 1967;35:15-27.
72. Durrer D, Schoo L, Schuilenburg RM, Wellens HJ: The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation 1967;36:644-662.
73. Wellens HJ, Schuilenburg RM, Durrer D: Electrical stimulation of the heart in patients with Wolff-Parkinson-White syndrome, type A. Circulation 1971;43:99-114.
74. Wellens HJJ, Durrer D: Relation between the refractory period of the accessory pathway and ventricular frequency during atrial fibrillation in patients with the Wolff-Parkinson-White syndrome. Am J Cardiol 1974;34:777-782.
75. Gallagher JJ, Pritchett ELC, Sealy WC, et al: The preexcitation syndromes. Prog Cardiovasc Dis 1978;20:285-327.
76. Gallagher JJ, Sealy WC, Kassell J, Wallace AG: Multiple accessory pathways in patients with the preexcitation syndrome. Circulation 1976;54:571-591.
77. Jackman WM, Friday KJ, Scherlag BJ, et al: Direct endocardial recording from an accessory atrioventricular pathway, localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation. Circulation 1983;68:906-916.
78. Vaughan Williams EM: Classification of antiarrhythmic drugs. Pharmacol Ther 1975;1:115-138.
79. Weidmann S: Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibers. J Physiol 1955;129:568-582.
80. Johnson EA, McKinnon MG: The differential effect of quinidine and pyrilamine on the myocardial action potential at various rates of stimulation. J Pharmacol Exp Ther 1957;120:460-468.
81. Hondeghem IM, Katzung BG: Time-and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channel. Biochem Biophys Acta 1977;472:373-398.
82. Wasserman JA, Schwartz DJ, Fozzard HA: Relation between intracellular sodium and twitch tension in sheep cardiac Purkinje strands exposed to cardiac glycosides. Circ Res 1983;52:697.
83. Schechter DC: Background of clinical cardiac electrostimulation. II. Electrical regulation of rapid cardiac dysrhythmias. N Y State J Med 1972;72:270-284.
84. Kouwenhoven WB, Hooker DR, Langworthy OR: Current flowing through heart under conditions of electric shock. Am J Physiol 1932;100:344-352.
85. Wiggers CJ: Cardiac massage followed by countershock in revival of mammalian ventricles due to coronary occlusion. Am J Physiol 1936;116:161-162.
86. Beck CS, Pritchard WH, Feil HS: Ventricular fibrillation of long duration abolished by electric shock. JAMA 1947;135:985-986.
87. Zoll PM, Lïnenthal AJ, Gibson W, Paul MH, Norman LR: Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med 1956;254:727.
88. Zoll PM, Linenthal AJ: Termination of refractory tachycardia by external countershock. Circulation 1962;25:596-602.
89. Lown B: Defibrillation and cardioversion. Cardiovasc Res 2002;55:221-24.
90. Lown B, Amarasingham R, Neuman J, Berkovits B: Comparison of alternating current with direct current electroshock across the closed chest. Am J Cardiol 1962;10:223-233.
91. Lown B, Fakhro AM, Hood WB. Thorn GW: The coronary care unit: New perspectives and directions. JAMA 1967;199:188.
92. Lown B, Amarasingham R, Neuman J: New method for terminating cardiac arrhythmias. JAMA 1962;182:548.
93. Mower MM, Reid PR: Historical development of the automatic-implantable cardioverter-defibrillator. In: Naccarelli GV, Veltri EP, eds. Implantable Cardiovener fibrillators. Boston: Blackwell Scientific Publications, 1993:15-25.
94. Mirowski M, Reid TR, Mower MM, et al: Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324.
95. Jackman WM, Zipes DP: Low-energy synchronous cardioversion of ventricular tachycardia using a catheter in a canine model of subacute myocardial infarction. Circulation 1982;66:187-195.
96. Zipes DP, Jackman WM, Heger JJ, et al: Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: Low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 1982;103:789-794.
97. Mirowski M: The automatic implantable cardioverter-defibrillator. An overview. J Am Coll Cardiol 1985;6:461-466.
98. Schechter DC: Background of clinical cardiac electrostimulation. IV. Early studies on feasibility of accelerating heart rate by means of electricity. N Y State J Med 1972;395-404.
99. Schechter DC: Background of clinical cardiac electrostimulation. V. Direct electrostimulation of heart without thoracotomy. N Y State J Med 1972;605-619.
100. Zoll PM: Resuscitation of the heart in ventricular standstill by external electric stimulation. N Engl J Med 1952;247:768-771.
101. Schechter DC: Background of clinical cardiac electrostimulation. VI. Precursor apparatus and events to the electrical treatment of complete heart block. N Y State J Med 1972;953-961.
102. Furman S, Schwedel JB: An intracardiac pacemaker for Stokes-Adams seizures. N Engl J Med 1959;261:943.
103. Parsonnet V: Routine implantation of permanent transvenous pacemaker electrodes in both chambers: A technique whose time has come. Pacing Clin Electrophysiol 1981;4:109-112.
104. Elmquist R, Senning A: Implantable pacemaker for the heart. In Smyth CN, ed: Medical Electronics, Proc Sec Int Conf on Med Electronics. Paris, June 1959. London: Iliffe & Sons, 1960.
105. Hunter SW, Roth NA, Bernardez D, Noble JL: A bipolar myocardial electrode for complete heart block. Lancet 1959;79:506-508.
106. Leatham A, Cook P, Davies JG: External electric stimulator for treatment of ventricular standstill. Lancet 1956;2:1185.
107. Greatbatch W: Twenty-five years of pacemaking. Pacing Clin Electrophysiol 1984;7:143-147.
108. Jeffrey K: Cardiac pacing and electrophysiology at millennium's end: Historical notes and observations. Pacing Clin Electrophysiol 1999;22:1713-1717.
109. Jeffrey K, Parsonnet V: Cardiac pacing. 1960-1985. A quarter century of medical and industrial innovation. Circulation 1998;97:1978-1991.
110. Friedberg CK: Diseases of the Heart. Third Edition. Philadelphia: WB Saunders, 1966.
111. Lown B, Wolf M: Approaches to sudden death from coronary heart disease. Circulation 1971;44:130-142.
112. Wyse GD, Talajic M, Haflee GE, et al: Antiarrhythmic drug therapy in the Multicenter Unsustained Tachycardia Trial (MUSTT): Drug testing and as-treated analysis. J Am Coll Cardiol 2001;38:344-351.
113. The ESVEM Investigators: Determinants of predicted efficacy of antiarrhythmic drugs in the Electrophysiologic Study Versus Electrocardiographic Monitoring trial. Circulation 1993;87:323-329.
114. The Antiarrhythmics Versus implantable defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
115. The Cardiac Arrhythmia Pilot Study (CAPS) Investigators: Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS. Am J Cardiol 1988;61:501-509.
116. Echt DS, Liebson PR, Mitchell LB, et al: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-788.
117. Al-Khatib SM, Allen NM, La Pointe A, et al: Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000. Am J Cardiol 2003;91:91-93.
118. Surawicz B, Pellegrino ED, eds: Sudden Cardiac Death. New York: Grune & Stratton, 1964.
119. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK: Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 2002;288:3008-3013.
120. Theng ZJ, Croft JB, Giles, WH, Mensah GA: Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163.
121. Teerlink JU, Jalaluddin M, Anderson S, et al: Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 2000;101:4046.
122. de Vreede-Swagemakers JJM, Gorgels APM, Dubois-Arbouw WI, et al: Out-of-hospital cardiac arrest in the 1990s: A population-based study in the Maastricht area in incidence, characteristics and survival. J Am Coll Cardiol 1997;30:1500-1505.
123. Jouven X, Desnos M, Guerot C, Ducimetierè P: Predicting sudden death in the population. The Paris prospective study I. Circulation 1999;99:1978-1983.
124. Spooner PM, Albert C, Benjamin EJ, et al: Sudden cardiac death, genes, and arrhythmogenesis. Consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute Workshop. Part II. Circulation 2001;103:2447-2452.
125. Shinbane JS, Wood MA, Jensen DN, et al: Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-715.
126. Gonzalez R, Scheinman M, Margaretten W, Rubinstein M: Closed chest electrode-catheter technique for His bundle ablation in dogs. Am J Physiol 1981;241:H283-H287.
127. Scheinman MM, Morady F, Hess DS, Gonzalez R: Catheter induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 1982;248:851-855.
128. Gallagher JJ, Svenson RH, Kassell JH, et al: Catheter technique for closed chest ablation of the atrioventricular conduction system: a therapeutic alternative for the treatment of refractory supraventricular tachycardia. N Engl J Med 1982;306:194-200.
129. Jackman WM, Wang XZ, Friday KJ, et al: Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 1991;324:1605-1611.
130. Jackman WM, Beckman KJ, McCleland JH, et al: Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 1992;327:313.
131. Olshansky R, Okumura K, Hess PG, et al: Demonstration of an area of slow conduction in human atrial flutter. J Am Coll Cardiol 1990;16:1639-1648.
132. Jais P, Haissaguerre M, Shah DC, et al: A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-576.
133. Cox JL: The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg 1991;101:584-592.
134. Darbar D, Olgin JE, Miller JA, Friedman PA: Localization of the origin of arrhythmias for ablation: From electrocardiography to advanced endocardial mapping systems. J Cardiovasc Electrophysiol 2001;12:1309-1325.
135. Schwartz PJ: Idiopathic long QT syndrome: Progress and questions. Am Heart J 1985;109:399-411.
136. Keating M, Atkinsin D, Dunn C, et al: Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991;252:704-706.
137. Splawski l, Shen J, Timothy KW, et al: Spectrum of mutations in long QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, KCNE2. Circulation 2000;102:1178-1185.
138. Priori SG, Schwartz PJ, Napolitano C, et al: Risk stratification in the long QT syndrome. N Engl J Med 2003;348:1866-1874.
139. Nademanee K, Veerakul G, Nimmanit S: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-2600.
140. Brugada J, Brugada R, Brugada P: Right bundle branch block and ST-segment elevation in leads V-1 though V-3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1997;96:2595-2600.
141. Chen QY, Kirsch GE, Zhang DM, et al: Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-296.
142. Swan H, Puppo K, Viitasalo, Heikkila P, et al: Arrhythmic disorder mapped to chromosome 1q42-1q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999;34:2035-2042.
143. Nelson SD, Sparks EA, Graber HL, Boudoulas H, et al: Clinical characteristics of sudden death victims in heritable (chromosome 1pl-1ql) conduction and myocardial disease. J Am Coll Cardiol 1998;32:1717-1723.
144. Brugada R, Tapscott T, Czernuszewicz CZ, et al: Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-913.